Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PAHC | US
-0.45
-2.07%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
21.31
21.34
21.38
20.87
Phibro Animal Health Corporation develops manufactures and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health Mineral Nutrition and Performance Products. The company develops manufactures and markets products for poultry swine beef and dairy cattle aquaculture and dogs. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. The company also offers nutritional specialty products which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. In addition it manufactures and markets formulations and concentrations of trace minerals such as zinc manganese copper iron and other compounds; and various specialty ingredients for use in the personal care industrial chemical and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry swine and cattle integrators as well as through commercial animal feed manufacturers wholesalers and distributors. It operates in the United States Latin America Canada Europe the Middle East Africa and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck New Jersey.
View LessGood Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
19.8%1 month
34.9%3 months
45.4%6 months
60.1%367.83
10.57
3.48
2.05
0.53
18.89
1.28
1.66
94.08M
863.13M
863.13M
2.17
8.57
-93.50
7.10
0.90
2.05
2.86
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.97
Range1M
3.47
Range3M
6.56
Rel. volume
0.87
Price X volume
3.80M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
PetIQ Inc | PETQ | Drug Manufacturers-Specialty & Generic | 30.87 | 923.02M | 0.13% | 83.11 | 178.54% |
Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 16.515 | 761.79M | 6.34% | 10.85 | 73.76% |
Ironwood Pharmaceuticals Inc | IRWD | Drug Manufacturers-Specialty & Generic | 4.3 | 693.71M | 0.94% | 50.25 | -199.01% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 17.9 | 506.39M | -4.48% | n/a | 0.00% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 4.42 | 495.19M | 0.00% | n/a | 117.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.95 | 450.75M | 3.34% | n/a | -329.45% |
Elite Pharmaceuticals Inc | ELTP | Drug Manufacturers-Specialty & Generic | 0.3933 | 420.15M | -6.31% | 19.50 | 0.00% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 3.08 | 408.33M | 8.07% | n/a | 42.12% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 2.12 | 331.23M | 1.44% | n/a | -471.04% |
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 5.5 | 301.75M | 2.42% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 18.89 | 17.21 | Par |
Ent. to Revenue | 1.28 | 334.38 | Cheaper |
PE Ratio | 367.83 | 26.92 | Expensive |
Price to Book | 3.48 | 12.15 | Cheaper |
Dividend Yield | 2.17 | 2.77 | Poor |
Std. Deviation (3M) | 45.39 | 68.34 | Lower Risk |
Debt to Equity | 2.05 | -1.00 | Expensive |
Debt to Assets | 0.53 | 0.48 | Par |
Market Cap | 863.13M | 5.31B | Emerging |